Related Experiment Video
Updated: Aug 15, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cells
Yan Jin1, Wai Keung Leung, Joseph Jao-Yiu Sung
1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Abstract:
The retinoblastoma (RB) tumor suppressor protein, pRB, plays an important role in the regulation of mammalian cell cycle. Furthermore, several lines of evidence suggest that pRB also involves in the regulation of apoptosis. In the present study, the degradation of pRB was observed in apoptotic gastric tumor cells treated with a new potent anti-tumor component, tripchlorolide (TC). The inhibition of pRB degradation by a general cysteine protease inhibitor IDAM resulted in the reduction of the apoptotic cells. Furthermore, the survival of the gastric tumor cells under the TC treatment was enhanced by an over-expression of exogenous pRB. These results suggest that the pRB degradation of the gastric tumor cells under the TC treatment involves in the apoptotic progression. In addition, the same extent of TC-induced pRB-degradation was detected in the gastric tumor cells containing a p53 dominant-negative construct, indicating that this kind of pRB degradation is p53-independent.
Insights
Tripchlorolide (TC) induces retinoblastoma (RB) protein degradation, promoting apoptosis in gastric tumor cells. This degradation is p53-independent, suggesting a novel therapeutic target for cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- The retinoblastoma (RB) protein is a key regulator of the mammalian cell cycle.
- Evidence suggests RB also plays a role in regulating apoptosis.
- Gastric tumor cells are a focus for novel anti-cancer therapies.
Purpose of the Study:
- To investigate the role of RB protein degradation in apoptosis induced by tripchlorolide (TC) in gastric tumor cells.
- To determine if RB degradation is essential for TC-induced apoptosis.
- To elucidate the involvement of p53 in TC-induced RB degradation.
Main Methods:
- Treatment of gastric tumor cells with tripchlorolide (TC).
- Assay for retinoblastoma (RB) protein degradation.
- Inhibition of RB degradation using a cysteine protease inhibitor (IDAM).
- Over-expression of exogenous RB.
- Utilizing p53 dominant-negative constructs.
Main Results:
- Tripchlorolide (TC) treatment led to the degradation of RB protein in apoptotic gastric tumor cells.
- Inhibiting RB degradation with IDAM reduced the number of apoptotic cells.
- Over-expressing RB enhanced gastric tumor cell survival under TC treatment.
- TC-induced RB degradation occurred independently of p53.
Conclusions:
- RB protein degradation is involved in the apoptotic progression of gastric tumor cells treated with TC.
- The observed RB degradation is a p53-independent mechanism.
- Targeting RB degradation may represent a novel therapeutic strategy for gastric cancer.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

